Skip to NavigationSkip to content

News

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its ability to...
AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European...
The amount of opioids prescribed to patients in the United States has fallen to a 15 year low according to data released by the FDA.
Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the...
Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a sum broken down into an up...
New NHS guidelines will encourage doctors to incorporate mental health therapists into practice surgeries in an effort to bring more physical and...
The US Food and Drug Administration is warning consumers and pet owners not to use products that have been manufactured by the homeopathic medicine...
Swiss multinational Novartis is set to create up to 450 new jobs following the investment of 90 million Swiss Francs (£71 million) into the...
Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 overweight and...
The FDA has opted to refuse approval to Akcea and Ionis’ Waylivra (volanesorsen) for the treatment of the ultra-rare hereditary condition familial...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches